Trials / Completed
CompletedNCT03863379
Sarcopenic Obesity in Neurodisabilities
Sarcopenic Obesity in Neurodisabled People
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Dionyssiotis, Yannis, M.D. · Individual
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | whole body DXA | Measurements of body composition may be used to study how lean body mass and body fat change during health and disease and have provided a research tool to study the metabolic effects of obesity and various wasting conditions. DXA measurements are based in part on the assumption that the hydration of fat-free mass remains constant at 73%. |
Timeline
- Start date
- 2019-05-02
- Primary completion
- 2021-06-15
- Completion
- 2022-05-15
- First posted
- 2019-03-05
- Last updated
- 2023-01-27
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03863379. Inclusion in this directory is not an endorsement.